Stonepine Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-309,100
| Closed | -$5M | – | 54 |
|
|
2024
Q3 | $5M | Buy |
309,100
+4,100
| +1% | +$66.3K | 3.16% | 7 |
|
|
2024
Q2 | $2.51M | Buy |
305,000
+200,976
| +193% | +$1.65M | 2.29% | 9 |
|
|
2024
Q1 | $1.54M | Buy |
+104,024
| New | +$1.54M | 1.22% | 13 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$16K | – | 18 |
|
|
2020
Q1 | $16K | Buy |
+1,000
| New | +$16K | 0.02% | 27 |
|
|
2018
Q3 | – | Sell |
-149,659
| Closed | -$4.24M | – | 34 |
|
|
2018
Q2 | $4.24M | Buy |
+149,659
| New | +$4.24M | 2.57% | 14 |
|